6 Patents
- 0 cites
- US122408402025Amide-substituted Heterocyclic Compounds for the Treatment of Conditions Related to the Modulation of IL-12, IL-23 And/or Ifn-alpha
Bristol-myers Squibb Company
0 cites - US1217297520241h-indazole Carboxamides as Receptor-interacting Protein Kinase 1 Inhibitors (RIPK1)
Bristol-myers Squibb Company
0 cites - 0 cites
- 0 cites
- 0 cites